Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-05-03Clinical Trial Update: VItamin D as a Novel Determinant of Injurious Cardiac Remodelling After acuTE Myocardial Infarction
This document reports on a clinical study evaluating whether vitamin D influences injurious cardiac remodeling after an acute myocardial inf…
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor [Phase 4]
A Phase 4 study is evaluating whether ticagrelor can reduce microvascular dysfunction after acute myocardial infarction. The document notes …
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
A clinical trial update describing a pilot project to develop a medical rehabilitation system in the Russian Federation, sponsored by St. Pe…
-
CLINICAL_TRIALS research · 2018-04-24Clinical Trial Update: COmprehensive Remote Ischemic Conditioning in Myocardial Infarction [NA]
This document provides a clinical trial update for comprehensive remote ischemic conditioning in myocardial infarction, specifically anterio…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI) [Phase 1, Phase 2]
Phase I/II clinical trial evaluating postconditioning in acute myocardial infarction has completed; results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: ECG Identifying the Culprit Coronary Artery
This clinical trial update describes using ECG to identify the culprit coronary artery in patients with acute myocardial infarction; the cur…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site
The Johns Hopkins University–sponsored registry evaluating non-primary angioplasty at hospitals without on-site surgical capability has comp…
-
FDA approval · 2018-04-09FDA Approved: VALSARTAN — Original Application (SQUARE PHARMACEUTICALS LIMITED)
The FDA approved Square Pharmaceuticals Limited's original application for valsartan (generic valsartan).
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Evaluation of Feasibility of Radial Access for Primary Angioplasty and to Assess it in High Risk Subgroups
A completed trial evaluating the feasibility of radial artery access for primary angioplasty and its performance in high-risk subgroups.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel
A completed clinical trial compared ticagrelor against a very low-dose rivaroxaban regimen with clopidogrel in patients with Acute Coronary …
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: IMproving reModeling in Acute myoCardial Infarction Using Live and Asynchronous TElemedicine. [NA]
Clinical trial update from Singapore investigates improving remodeling after acute myocardial infarction using live and asynchronous telemed…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction [NA]
This clinical trial update reports completion of a study evaluating interventions to support long-term adherence and to reduce cardiovascula…
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Influence of Virtual Reality on Myocardial Revascularization [NA]
The clinical trial investigating virtual reality during myocardial revascularization for patients with myocardial infarction has completed.
-
CLINICAL_TRIALS research · 2018-03-16Clinical Trial Update: the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice
This clinical trial update investigates how cholesterol efflux capacity relates to coronary artery disease in real-world clinical practice, …
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: AngelMed for Early Recognition and Treatment of STEMI [Phase 3]
Phase 3 trial update for the AngelMed Guardian System targeting STEMI, with the study status shown as completed.
-
CLINICAL_TRIALS research · 2018-03-14Clinical Trial Update: Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring [Phase 4]
A Phase 4 clinical trial compares activated partial thromboplastin time (APTT) versus anti-Xa activity for monitoring heparin therapy. The s…
-
CLINICAL_TRIALS withdrawal · 2018-03-13Clinical Trial Update: Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention [Phase 3]
Phase 3 trial of Aggrastat (tirofiban) in patients undergoing percutaneous coronary intervention for myocardial infarction or acute coronary…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients
The ISAR-Trial evaluating innovative stratification of arrhythmic risk in female myocardial infarction patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction
ISAR-Trial investigates long-term stratification of arrhythmic risk in patients with myocardial infarction. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Autonomic Regulation Trial (ART)
The Autonomic Regulation Trial (ART) for myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery
This clinical trial update reports on the ISAR-Trial (Innovative Stratification of Arrhythmic Risk) in patients with myocardial infarction a…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus
Clinical trial ISAR-Trial update related to diabetes mellitus with myocardial infarction as the condition. The study status is completed.
-
FDA approval · 2018-03-09FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Brilinta (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Improving Intermediate Risk Management. MARK Study
The MARK Study trial has completed, reporting results on intermediate risk management in patients with myocardial infarction, angina pectori…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease [Phase 1]
Phase 1 trial of VEGF-D gene therapy delivered endocardially for severe coronary heart disease has completed, enrolling patients with angina…